Диссертация (1140228), страница 21
Текст из файла (страница 21)
et al. Uterine vascularity during stimulation andits correlation with implantation in in-vitro fertilization. Human Reprod 1995; 10:6: 1497-1501.63.Beer A.E., Kwak J. Reproductive medicine program Finch University of HealthScience. Chicago Medical School. 2000.9664.Beerendok C.C., Van Dop P.A., Braat D.D., Merkus J.M. Ovarianhyperstimulation syndrom: facts and fallacies // Obstet. Gynecol.
Suerv. 1998.Vol. 53. №7. P. 439-449.65.Bengoetxea H, Argandona EG, Lafuente JV (2008). "Effects of visual experienceon vascular endothelial growth factor expression during the postnataldevelopment of the rat visual cortex". Cerebral Cortex. 18 (7): 1630-39.66.Bergh P.A., Novot D. Ovarian Hyperstimulation syndrome. // A review ofpathophysiology. J.
Ass. Reprod. Genet. 1992. №9. P. 429-438.67.Bertina R.M. Molecular risk factors for thrombosis. // Thrombosis andHaemostasis J. 1999. Vol. 82. №2. P.601-610.12568.Bick R.L., Hoppensteadt D. Recurrent miscarriage syndrome and infertility due toblood coagulation protein/platelet defects: a review and update // Clin Appl.Throb. Hemost. 2005 Jan; 11(1):1-13.69.Binder N.K., Evans J., Gardner D.K., Salamonsen L.A., Hannan N.J. Endometrialsignals improve embryo outcome: functional role of vascular endothelial growthfactor isoforms on embryo development and implantation in mice //HumanReproduction and Embryology.
2014. Vol. 29. № 10. P. 2278–2286.70.Boudjenah R., Molina-Gomes D.et al. Associations between Individual andcombined polymorphisms of the TNF and VEGF genes and the embryoimplantation rate in patients undergoing in vitro fertilization (IVF) programs //PLoS One. 2014. Vol.т9. №т9: е108287. – Doi: 10.1371/journal.pone.0108287.71.Brenner B. Inherited thrombophilia and pregnancy loss.
// Thrombosis andHomoeostasis J. 1999. Vol. 82. №2. P. 634-641.72.Cheung C., Singh M., Brace R. Expression of vascular endothelial growth factorand its ribonucleinic acid in ovine placenta and fetal membranes. Proc SocGynecol Invest 1995; 42: Abstr. P393.73.Cöl-Madendag I., Madendag Y., Altinkaya S.Ö., Bayramoglu H., Danisman N.The role of VEGF and its receptors in the etiology of early pregnancy loss//Gynecol. Endocrinol. — 2014.
Vol. 30. № 2. P. 153–156.74.Coulam C.B. The role of antiphospholipid antibodies in reproduction: questionsanswered and raised at the 18th Annual Meeting of the American Society ofReproductive Immunology.// Am J. Reprod. Immunol. 1999. Jan.Vol.41(1):P.1-4.75.De Franchis R., Buoninconti A., Fermo I., Sebastio G., Sperandeo M.P., MazzolaG., Cerbone A.M., Soriente L., Orifice G., Di Minno G., D’Angelo A., Andria G.,Increased thrombotic risk for patients with associated 844ins68 mutation of thecystamonirte B-synthaze (CBS)gene and the 677C->T mutation of themethylenetetrahydrofolate reductase (MTHFR) gene. // Am.
J. Hum. Gen. 1998.63. A210 (abstract).12676.De Vries J.I., Dekker G.A., Huijgens P.C., Jakobs C., Blomberg B.M., van GeijnH.P. Hyperhomocysteinemia and protein S deficiency in complicated pregnancies// Br. J. Obstet. Gynecol. 1997.Vol. 104.P.1248-1254.77.Egbase P.E., Al Sharhan M., Diejomaoh M., Grudzinskas J.G. Antiphospholipidantibodies in infertile couples with two consecutive miscarriages after in-vitrofertilization and embryo transfer.// Human Reproduction.
June 1999. Vol. 14.No.6. P. 1483-1486.78.Evans P.W., Wheeler T., Anthony F.W., Osmond C.A. Longitudinal study ofmaternal serum vascular endothelial growth factor in early pregnancy. HumReprod 1998; 13:1057-1062.79.Ferrara N, Gerber HP (2002). "The role of vascular endothelial growth factor inangiogenesis". Acta Haematol'. 106 (4): 148-56.80.Ferraresi P. Marchetti G. Legnani C. et al. The heterozygous 20210G/Aprothrombin genotype is associated with early venous thrombosis in inheritedthrombophillias and is not increased in frequency in artery disease.
Arteroscl.Throb. Vasc. Biol. 1997. Vol. 17. P. 2418-2422.81.Fiedler K., Wurfel W. Effectivity of heparin in assisted reproduction. Eur J MedRes. 2004. Apr30; 9(4):207-1482.Foad A., Ariel M., Israel Y., Ami A., Joseph B., Lessing and Michael J.Kupferminc. Increased rates of thrombophilia in women with repeated IVFfailures.
// Human Reproduction. 2004. Vol. February. Vol. 19. N. 2. P. 368-370.83.Genievskaya M., Makatsaria A. Low molecular weight heparin (Fraxiparine) aslongterm single agent therapy in pregnant with antiphospholipid syndrome // 16th Congress on thrombosis and haemostasis. Porto 2000. 12.84.Gerhardt A., Scharf R.E., Beckmann M.W., Struve S., Bender H.G., Pillny M.,Sandmann W., Zotz R.B. Prothrombin and factor V mutation in women with ahistory of thrombosis during pregnancy and puerperium // N.
Engl. J. Med. –2000. Vol.342(6). P.374-380.85.Glueck C.J., Awadalla S.G., Phillips H., Cameron D., Wang P., Fontaine R.N.Polycysticovarysyndrome,infertility,familialthrombophilia,familial127hypofibrinolysis, recurrent loss of in vitro fertilized embryos, and miscarriage.//Fertility and sterility. 2000. Vol.74.№2. P. 394-397.86.Glueck C.J., Phillips H., Cameron D., Wang P., Fontaine R.N., Moore S.K.,Sieve-Smith L., Tracy T.
The 4G/4G polymorphism of the hypofibrinolytic PAI-1gene: an independent risk factor for serious pregnancy complications. Metabolism2000;49:845–852.87.Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Eldor A. Increased Frequencyof the Hypofibrinolytic 4G/4G Polymorphism of the Plasminogen ActivatorInhibitor-1 (PAI-1) Gene in Women with Obstetric Complications. ObstetGynecol 2001;97:44–48.88.Goldman-Wohlh D.S., Ariel I. Tie-2 and angiopoetine -2 expression at the fetalmaternal interface: a receptor ligand model for vascular remodelling. HumReprod 2000;6:1:81—87.89.Gordon J., Shifren J.L., Foulk R.A.
et al. Angiogenesis in the human femalereproductive tract. Obstet Gynecol Surv 1995; 50: 688-697.90.Grandone E., Colaizzo D., Vergura P., Cappucci F., Vecchione G., Lo Bue A.,Cittadini E., Margaglione M. Age and homocysteine plasma levels are risk factorsfor thrombotic complications after ovarian stimulation. // Hum. Reprod. 2004Aug; Vol.
19(8): 2004 Jun 03. P. 1796-1799.91.Grandra M.J., Fraga M., Saravia J.P., Andrade J. Anticardiolipin antibodies andhigh risk pregnancy. // 16-th Congress on thromb and haemost. Porto. 2000.92.Gris J.C., Schved J.F., Neveu S. Et al., Impaired fibrinolytic capacity in womenwith early recurrent unexplained miscarriages: a LMWH favours successfulpregnancy.// Fibrinolisis. 1994.
Vol. 8(Suppl 1). 91 AB: 254.93.Guidelines on the investigation and management of thrombophilia. The BritishCommittee of standards in Hematology // J. Clin Pathol. 1990.№43. 703-9.94.Haemostasis and Thrombosis: Basis Principles and Clinical Practice. Ed. RobertW. Colman et al. Fourth Edition. 2001.12895.Hamai Y., Fujii T., Yamashita T. Evidence for basic fibroblast growth factor as acrucial angiogenic growth factor, released from human trophoblasts during earlygestation. Placenta 1998; 19: 14-55.96.Hannan N.J., Paiva P., Meehan K.L., Rombauts L.J., Gardner D.K., SalamonsenL.A.
Analysis of fertility – related soluble mediators in human uterine fluididentifies VEGF as a key regulator of embryo implantation //Endcrinology. 2011.Vol.152. №12. P. 4948–4956.97.Herman A., Ron-El R., Golan A., et all. Pregnancy rate and ovarianhyperstimulation after luteal human chorionic gonadotropin in IVF stimulatedwith a-GnRH and menotropins // Fertility and Sterility. 1990. Vol. 9. P.
92-96.98.Hessmer M.J., Luhm R.A., Pearson S.L., et al. Prevalence of prothrombinG20210A factor, FV G1691A (Leiden) and methylenetetrahydrofolate reductase(MTHFR) C677T in seven different population determined by multiplex allenespecific risk. // Tromb. Haemost. 1999. Vol.81.
P. 733.99.Kianpour M., Nematbakhsh M. et al. Serum and peritoneal fluid levels ofvascular endothelial growth factor in women with endometriosis //InternationalJournal Fertility Sterility. 2013. Vol.7. № 2. Р. 96–99.100. Kupferminc M. J. Thrombophilia and pregnancy // Reprod Biol Endocrinol.2003; 1: 111.101. Kutteh W.H., Yetman D.L., Chatilis S.J., Crain J. Effect of antiphospholipidantibodies in women undergoing in-vitro fertilization: role of heparin and aspirin.// Hum. Reprod. 1997. Jun.
Vol. 12(6). P.1171-1175.102. Manolea M.M., Dijmarescu A.L. et al. Evaluation of the implantation sitemorphology in spontaneous abortion //Rom Journal Morfology Embryology.2015. Vol. 56. № 1. P. 125–131.103. Martinelli I., Cattaneo M., Taioli E et al. Genetic risk factors for superficialvein thrombosis.
// Thromb. Haemost., 1999; 82: 1215.104. Martinelli I., Taioli E., Rajni G., Levi-Seti P., Passamonti S.M., Battajlioli T.,Lodigiani C., Mannucci P.M Embryo implantation after assisted reproductive129procedures and maternal thrombophilia // Haematologica. 2003.July.V.88. P.789793.105. McClure N., Healy D.L., Rogers P.A. W.
et al. Vascular endothelial growthfactor as capilarry permeability agent in ovarian hyperstimulation syndrome.Lancet 1994; 344: 235-236.106. McGowan B.M., Kay L.A., Perry D.J. Deep vein thrombosis followed byinternal jugular vein thrombosis as a complication of in vitro fertilization in awoman heterozygous for the prothrombin 3' UTR and factor V Leiden mutations// Am J. Haematol. 2003 Aug;73(4):276-278.107. Meinardi J.R., Middeldorp S., de Kam P.J., Koopman M.M., van PampusE.C., Hamulyak K., Prins M.H., Buller H.R., van der Meer J.// Risk of venousthromboembolism in carriers of factor V Leiden with a concomitant inheritedthrombophilic defect: a retrospective analysis. Blood Coagul Fibrinolysis.2001.Dec;Vol.12(8):P.713-20.108.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
